Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Cell Culture PD - Parallel System for Cell Culture Process Development

Product Image
Product Description

DASGIP Parallel Bioreactor Systems for process development with animal and insect as well as with human cell lines allow for advanced process control and automation.

Precise control of all relevant process parameters, user-defined profiles and innumerable automation features result in accelerated and highly efficient process development. Industry-leading communication standards support DoE, process historians and comprehensive data management.

Individual systems can be configured with assorted components and software functions to meet specific application requirements:

  • Parallel operation of four, eight or sixteen bioreactors
  • Excellent growth of e.g. CHO, Hybridoma and NS0 cell lines
  • Excellent scalability and reproducibility
  • Support of high cell densities up to 2x10^7 cells per mL
  • Small footprint achieved through using compact stackable modules
  • Predefined recipes for standard applications
  • Full controller scripting for easy scale-up and scale-down
  • Variable speed pump drives
  • Continuous and cyclic perfusion templates
  • Overhead drives
  • Individual temperature control via Heating Blanket and/or Cooling Finger
  • pH control using acid and base or CO2 and base
  • pO2 control with constant gassing or gassing on demand
  • Individual gas mixture from Air, O2, CO2 and N2
  • Thermal Mass Flow controlled gassing
  • Cascaded pO2 control using gas flow rates and oxygen enchrichment
  • Gassing to headspace, sparger and/or overlay
  • Level control and/or anti foam sensor
  • Optional integration to bioprocess analyzer, cell counter, HPLC, etc.
  • In-situ cell growth monitoring (optical density)
Product Cell Culture PD - Parallel System for Cell Culture Process Development
Company DASGIP
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

DASGIP
Rudolf-Schulten-Str. 5 52428 Jülich Germany

Tel: +49 (0)2461-980-0

Email: info@dasgip.de



Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Important Regulator of Immune System Decoded
Plasma cells play a key role in our immune system. Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function.
Bacterial Superglue for Faster Vaccine Development
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.
Enumeral, MD Anderson Enter Into Collaboration
Strategic collaboration aims to discover and develop potentially novel antibodies against specified targets for immunotherapy.
Joint venture for GlycoMar Limited and MicroA AS
Scottish biotechnology company GlycoMar and Norwegian technology company MicroA are pleased to announce their joint venture business Prasinotech Ltd. The new company is registered in Scotland.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!